Abstract
Introduction
Tumor enlargement is the most common parameter identifying disease progression during active surveillance, but the value and significance of the changes in tumor diameter and volume in the evaluation of tumor growth have not been compared.
Methods
This cohort study included 468 patients with high-risk thyroid nodule, in whom nodule size change was monitored using ultrasound, to compare the changes in tumor diameter and volume in assessing tumor growth.
Results
A total of 569 high-risk thyroid nodules were found in the 468 patients. A total of 14 nodules (2.5%) showed a diameter increase ≥ 3 mm. The number of nodules with a peak volume change exceeding 50% and 100% was 185 (32.5%) and 86 (15.1%), respectively. Among the 555 stable nodules, the number of nodules with volume fluctuations exceeding 50% and 100% was 171 (30.8%) and 72 (13.0%), respectively. Among 212 stable nodules at the baseline and in the first three follow-up, the percentage of peak volume fluctuations exceeding 50% (48.5% vs. 28.5%, p = 0.004) and 100% (26.5% vs. 8.3%, p < 0.001) in the nodules with the sum of three diameters (SOTDs) ≤ 1 cm was significantly higher than that of nodules with SOTDs > 1 cm. A statistically significant difference was also found in the range distribution of SOTDs ≤ 1 cm and SOTDs > 1 cm (p = 0.007).
Conclusions
Volume is not an appropriate method for determining tumor growth. Tumor diameter measurement alone serves as a better surrogate for disease progression in sonographically high-risk thyroid nodules than volume.
Similar content being viewed by others
References
Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T et al (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34(1):28–35. https://doi.org/10.1007/s00268-009-0303-0
Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K et al (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13(4):381–387
Zhang H, Zheng X, Liu J, Gao M, Qian B (2020) Active surveillance as a management strategy for papillary thyroid microcarcinoma. Cancer Biol Med 17(3):543–554
Lee EK, Moon JH, Hwangbo Y, Ryu CH, Cho SW, Choi JY et al (2022) Progression of low-risk papillary thyroid microcarcinoma during active surveillance: interim analysis of a multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma in Korea. Thyroid 32(11):1328–1336
Tuttle RM, Fagin JA, Minkowitz G, Wong RJ, Roman B, Patel S et al (2017) Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg 143(10):1015–1020
Oh HS, Ha J, Kim HI, Kim TH, Kim WG, Lim DJ et al (2018) Active surveillance of low-risk papillary thyroid microcarcinoma: a multi-center cohort study in Korea. Thyroid 28(12):1587–1594
Chung SR, Choi YJ, Lee SS, Kim SO, Lee SA, Jeon MJ et al (2021) Interobserver reproducibility in sonographic measurement of diameter and volume of papillary thyroid microcarcinoma. Thyroid 31(3):452–458
Tuttle RM, Fagin J, Minkowitz G, Wong R, Roman B, Patel S et al (2022) Active surveillance of papillary thyroid cancer: frequency and time course of the six most common tumor volume kinetic patterns. Thyroid 32(11):1337–1345
Ito Y, Miyauchi A, Kudo T, Higashiyama T, Masuoka H, Kihara M et al (2019) Kinetic analysis of growth activity in enlarging papillary thyroid microcarcinomas. Thyroid 29(12):1765–1773
Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A (2014) Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 24(1):27–34
Sugitani I, Fujimoto Y, Yamada K (2014) Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma. World J Surg 38(3):673–678. https://doi.org/10.1007/s00268-013-2335-8
Ito Y, Miyauchi A, Oda H (2018) Low-risk papillary microcarcinoma of the thyroid: a review of active surveillance trials. Eur J Surg Oncol 44(3):307–315
Cho SJ, Suh CH, Baek JH, Chung SR, Choi YJ, Chung KW et al (2019) Active surveillance for small papillary thyroid cancer: a systematic review and meta-analysis. Thyroid 29(10):1399–1408
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133
Jeong WK, Baek JH, Rhim H, Kim YS, Kwak MS, Jeong HJ et al (2008) Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 18(6):1244–1250
Park CS, Kim SH, Jung SL, Kang BJ, Kim JY, Choi JJ et al (2010) Observer variability in the sonographic evaluation of thyroid nodules. J Clin Ultrasound 38(6):287–293
Ho AS, Kim S, Zalt C, Melany ML, Chen IE, Vasquez J et al (2022) Expanded parameters in active surveillance for low-risk papillary thyroid carcinoma: a nonrandomized controlled trial. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2022.3875
Sakai T, Sugitani I, Ebina A, Fukuoka O, Toda K, Mitani H et al (2019) Active surveillance for T1bN0M0 papillary thyroid carcinoma. Thyroid 29(1):59–63
Ito Y, Miyauchi A, Fujishima M, Noda T, Sano T, Sasaki T et al (2022) Thyroid-stimulating hormone, age, and tumor size are risk factors for progression during active surveillance of low-risk papillary thyroid microcarcinoma in adults. World J Surg. https://doi.org/10.1007/s00268-022-06770-z
Sugitani I, Ito Y, Takeuchi D, Nakayama H, Masaki C, Shindo H et al (2021) Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the japan association of endocrine surgery task force on management for papillary thyroid microcarcinoma. Thyroid 31(2):183–192
Acknowledgements
The authors thank Mr. Yanlong Li for statistical guidance
Funding
This work was supported by the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (Grant No.: 2019XK320011) and the National High Level Hospital Clinical Research Funding (Grant No.: 2022-PUMCH-B-003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, C., Zhao, H., Lu, Y. et al. Criteria to Evaluate Tumor Enlargement During the Active Surveillance of High-Risk Thyroid Nodules: Which is Better, Diameter or Volume?. World J Surg 47, 3214–3221 (2023). https://doi.org/10.1007/s00268-023-07185-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-023-07185-0